TRIP
49
2
GD
62
5
CMCSA
44
-2
KLAC
72
2
WAT
49
2
STX
69
2
PSX
37
2
EFX
54
2
SYF
74
5
D
41
-4
ZION
71
2
MU
75
4
GOOGL
47
4
CAH
63
3
EMN
56
-2
SCHW
64
6
INTC
43
6
AIV
37
-2
PLD
30
2
APD
45
-2
TRIP
49
2
GD
62
5
CMCSA
44
-2
KLAC
72
2
WAT
49
2
STX
69
2
PSX
37
2
EFX
54
2
SYF
74
5
D
41
-4
ZION
71
2
MU
75
4
GOOGL
47
4
CAH
63
3
EMN
56
-2
SCHW
64
6
INTC
43
6
AIV
37
-2
PLD
30
2
APD
45
-2
Financhill
Back

John Hancock Preferred Income Fund III Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Buy
58

HPS
John Hancock Preferred Income Fund III

Last Price:
$14.41
Seasonality Move:
1.27%
Sell
32

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.68
Seasonality Move:
-18.07%
Buy
58
John Hancock Preferred Income Fund III (HPS) is a Buy

Is John Hancock Preferred Income Fund III a Buy, Sell or Hold?

  • The current John Hancock Preferred Income Fund III [HPS] share price is $14.41. The Score for HPS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • HPS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.59. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HPS Stock Price Chart

What is John Hancock Preferred Income Fund III's stock price today?

  • The John Hancock Preferred Income Fund III share price today is $14.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HPS is experiencing slight buying pressure.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing slight buying pressure.

HPS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 34.72 Sell
Chaikin Money Flow: 8579 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.46 - 14.92) Sell
Bollinger Bands (100): (14.63 - 15.39) Sell

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 44.79 Sell
Chaikin Money Flow: 9780 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 12.35) Sell
Bollinger Bands (100): (12.23 - 15.15) Sell

HPS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.41 Buy
20-day SMA: 14.63 Sell
50-day SMA: 15.03 Sell
200-day SMA: 14.7 Sell
8-day EMA: 14.43 Sell
20-day EMA: 14.62 Sell
50-day EMA: 14.61 Sell
200-day EMA: 9.53 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.09 Sell
20-day SMA: 11.62 Sell
50-day SMA: 12.8 Sell
200-day SMA: 11.89 Sell
8-day EMA: 11.86 Sell
20-day EMA: 11.96 Sell
50-day EMA: 12.6 Sell
200-day EMA: 12.22 Sell

John Hancock Preferred Income Fund III Earnings Growth & HPS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

John Hancock Preferred Income Fund III Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):